GGrantIndex
Sort

146,196 grants matching diabetes

Ethnic Disparities in Diabetes Complications

$857,583
Kaiser Foundation Research Institute · R01 · FY2004 · DK

Cerebral hemodynamic impairment in symptomatic and asymptomatic Alzheimer's Disease

$857,527
Deqiang Qiu · Emory University · R01 · FY2022 · AG

ARIC Neurocognitive Study (ARIC-NCS) Renewal 4 of 5

$857,455
Lynne E Wagenknecht · Wake Forest University Health Sciences · U01 · FY2016 · HL

Neurobiological mechanisms of altered cortical plasticity in Type-2 diabetes mellitus

$857,443
Peter J Fried · Beth Israel Deaconess Medical Center · R01 · FY2022 · AG

Lysosome biogenesis and homeostasis

$857,347
Rosa Puertollano-Moro · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL

Development and Validation of Animal Models and/or Outcome Measures

$857,308
Joshua J.c. Rosenthal · Marine Biological Laboratory · U19 · FY2021 · NS

Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis

$857,294
William James Adams · Riparian Pharmaceuticals, Inc. · R44 · FY2016 · HL

Nikon Multiphoton (MP) Imaging System

$857,209
James E Cassat · Vanderbilt University Medical Center · S10 · FY2023 · OD

Regulation of Aldosterone: The Effect of Statins

$856,893
Gail Kurr Adler · Brigham And Women'S Hospital · R01 · FY2020 · HL

Elucidating the Role of Adipokines in Mediating and Predicting HF Associated with Obesity

$856,837
Chiadi E Ndumele · Johns Hopkins University · R01 · FY2019 · HL

Genome-wide association of common alleles with long-term diabetic complications

$856,830
Andrew D Paterson · Hospital For Sick Chldrn (Toronto) · R01 · FY2006 · DK

PLACENTAL ANGIOGENIC FACTORS &UAEC /PAEC NO PRODUCTION

$856,790
University Of Wisconsin Madison · P01 · FY2003 · HD

Quantitative measurement of T1D risk through molecular signature analysis

$856,742
Martin John Hessner · Medical College Of Wisconsin · DP3 · FY2013 · DK

Cognitive Function in SLE (COGNITION)

$856,727
Robin L Brey · University Of Texas Hlth Science Center · R01 · FY2008 · NS

Effect of obesity on HIV pathogenesis, antiretroviral therapy, and metabolic comorbidities

$856,702
Charles T Roberts · Oregon Health & Science University · R01 · FY2019 · DK

Collaborative IVR Platform for Multilingual Patient Outreach and Education

$856,683
William Z Tan · Transcendent International, Llc · R44 · FY2010 · DK

Microbiome and AD/ADRD Risk in SOL

$856,580
Natalia Palacios · University Of Massachusetts Lowell · R01 · FY2025 · AG

AC5 inhibitor for heart failure

$856,579
Dorothy E Vatner · Vasade Biosciences, Inc. · R44 · FY2014 · HL

Integrating Social and Systems Science Approaches to Promote Oral Health Equity

$856,541
Mary Evelyn Northridge · New York University · R01 · FY2014 · DE

Lipidomics Biomarkers Link Sleep Restriction to Adiposity Phenotype, Diabetes, and Cardiovascular Risk

$856,469
Bruce S Kristal · Brigham And Women'S Hospital · R01 · FY2020 · HL

RES FACIL CONST: ISLET-KIDNEY TRANSPLANTS FOR TREATMENT OF DIABETIC ESRD

$856,408
Massachusetts General Hospital · C06 · FY2004 · RR

PATHOGENESIS AND PREVENTION OF IDDM

$856,394
Stanford University · P01 · FY2000 · DK

Center for Iron and Heme Disorders (CIHD)

$856,348
John Dearborn Phillips · University Of Utah · U54 · FY2017 · DK

Renal Therapeutic Angiogenesis Using the Novel Biologic ELP-VEGF

$856,297
Gene Leflore Bidwell · Leflore Technologies, Llc · R42 · FY2024 · DK

Claude D. Pepper Older Americans Independence Center (OAIC)

$856,283
Marco Pahor · University Of Florida · P30 · FY2010 · AG